Competition is working, even as the FTC meddles in a takeover fight in a way that helped Pfizer.

We sold Novo Nordisk out of the portfolio due to two concerns that made us question the company’s ability to deliver ...

Novo Nordisk navigates competition and guidance challenges with strong profitability and upcoming oral Wegovy opportunities.

Novo investors on Stocktwits praised new CEO Mike Doustdar as “dynamic,” saying they remain confident in Novo’s long-term ...

US pharma giant Pfizer won a bidding war to acquire obesity drug developer Metsera, beating back an offer from Danish rival ...

Metsera said it expects the Pfizer deal to close promptly after a stockholder meeting scheduled for this coming Thursday ...

The companies announced a huge deal that will have implications for investors. Eli Lilly ( LLY 1.39%) and Novo Nordisk ( NVO ...

Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Novo Nordisk wasn ...

Wall Street major averages posted weekly loses amid an AI-tech trade that continued to struggle, with lower consumer ...

U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind weight-loss ...

Pfizer Inc. agreed to buy Metsera Inc. for up to $10 billion, prevailing over Novo Nordisk A/S in a tumultuous bidding war ...

A man’s dramatic collapse in the Oval Office and Trump officials’ reactions grabbed public attention, inspired Saturday Night ...